Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 95001-95050 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04804332
Removal of Intrauterine Retained Products of Conception (RPOC) After Miscarriage Guided by Hysteroscopy Trial. A Randomized Controlled Trial.
NARecruiting
244 participants
Started: Jul 12, 2021 · Completed: Dec 30, 2027
1 condition2 sponsors1 location
NCT05003635
External Vacuum Expansion: Evaluation in Breast Reconstructive Surgery Evaluation in Breast Reconstructive Surgery
NARecruiting
90 participants
Started: Jul 12, 2021 · Completed: Oct 31, 2026
1 condition2 sponsors3 locations
NCT04972838
AIR-B4: Remaking Recess (RR)
NAActive, not recruiting
264 participants
Started: Jul 11, 2021 · Completed: Dec 1, 2025
2 conditions7 sponsors3 locations
NCT04856085
Study of VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects With Chronic Hepatitis B Virus Infection
PHASE2Active, not recruiting
244 participants
Started: Jul 11, 2021 · Completed: Mar 31, 2026
1 condition1 sponsor37 locations
NCT04742894
Neural Bases of Vocal Sensorimotor Impairment in Aphasia
NARecruiting
100 participants
Started: Jul 11, 2021 · Completed: Feb 28, 2026
1 condition2 sponsors3 locations
NCT04824066
The Role of Wearable Devices in Cardiothoracic Surgery: Predicting and Detecting Early Postoperative Complications
N/ARecruiting
1,200 participants
Started: Jul 10, 2021 · Completed: Jun 30, 2027
1 condition2 sponsors1 location
NCT04917237
Non-disabling Ischemic Cerebrovascular Event With Apathy
N/ARecruiting
200 participants
Started: Jul 10, 2021 · Completed: Jun 10, 2024
4 conditions1 sponsor1 location
NCT04692103
Serial FES PET/CT to Measure Hormone Expression in Patients Undergoing Endocrine Targeted Therapy
PHASE2Active, not recruiting
2 participants
Started: Jul 10, 2021 · Completed: Apr 30, 2041
3 conditions1 sponsor1 location
NCT05006157
Pericardial Access With ViaOne Device
NAActive, not recruiting
10 participants
Started: Jul 10, 2021 · Completed: Jun 30, 2025
1 condition1 sponsor4 locations
NCT06090357
Biomechanical Functional Evaluation of Plantar Pressures After Foot and Ankle Surgeries
NARecruiting
100 participants
Started: Jul 10, 2021 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT06979921
PERformance of Multi-Cancer Early-detectIon Based on Various Biomarkers in fEmale BREAST Cancers, PERCEIVE-BREAST
N/AActive, not recruiting
496 participants
Started: Jul 10, 2021 · Completed: Dec 30, 2026
1 condition2 sponsors2 locations
NCT04591093
Auditory Performances With Different Stimulation Depths in Cochlear Implanted Subjects Using a Fine Structure Strategy
NARecruiting
32 participants
Started: Jul 10, 2021 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT06130150
Sexual Function in High-risk Pregnant Women
N/ARecruiting
400 participants
Started: Jul 10, 2021 · Completed: Jan 31, 2024
4 conditions1 sponsor1 location
NCT04624126
External Device for Erectile Dysfunction (3D-Erect)
NARecruiting
9 participants
Started: Jul 10, 2021 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT04972604
CureDuchenne Link®: A Resource for Research
N/ARecruiting
5,000 participants
Started: Jul 9, 2021 · Completed: Jul 9, 2031
2 conditions1 sponsor10 locations
NCT04996160
Palbociclib in Combination With Chemotherapy in Pediatric Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia (RELPALL2)
PHASE1Recruiting
22 participants
Started: Jul 9, 2021 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT04739813
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid in Combination With Polatuzumab (ViPOR-P) in Relapsed/Refractory B-cell Lymphoma
PHASE1Recruiting
55 participants
Started: Jul 9, 2021 · Completed: Apr 4, 2031
4 conditions1 sponsor1 location
NCT04547777
Phase 1 Trial of D2C7-IT in Combination With 2141-V11 for Recurrent Malignant Glioma
PHASE1Recruiting
90 participants
Started: Jul 9, 2021 · Completed: Jun 30, 2027
1 condition2 sponsors1 location
NCT04951219
A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)
PHASE3Active, not recruiting
1,000 participants
Started: Jul 9, 2021 · Completed: Apr 30, 2026
1 condition1 sponsor71 locations
NCT04888104
Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients
N/ARecruiting
225 participants
Started: Jul 9, 2021 · Completed: Dec 31, 2034
3 conditions2 sponsors9 locations
NCT04985500
ESP/PIF for Sternotomy
EARLY_PHASE1Active, not recruiting
225 participants
Started: Jul 9, 2021 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT03867643
Efficacy of Hepatitis B Vaccine Boosters Among Neonatally Vaccinated Children in Chongqing
N/ARecruiting
80 participants
Started: Jul 9, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05213234
Chronotherapy of 5-Aminosalicylic Acid in Ulcerative Colitis
NAActive, not recruiting
32 participants
Started: Jul 9, 2021 · Completed: Mar 31, 2026
1 condition2 sponsors2 locations
NCT03684564
RIvaroxaban for Stroke Patients With AntiPhospholipid Syndrome
PHASE2Active, not recruiting
43 participants
Started: Jul 9, 2021 · Completed: Aug 31, 2025
5 conditions8 sponsors6 locations
NCT04808752
Almonertinib as First-line Treatment in Patients With EGFR Mutations Positive in Advanced NSCLC With Brain Metastases
PHASE2Active, not recruiting
63 participants
Started: Jul 9, 2021 · Completed: Jul 15, 2024
1 condition2 sponsors1 location
NCT06325072
Set-up of a Platform for Personalized Diagnosis of Rare Kidney Diseases (NIKE)
NAActive, not recruiting
160 participants
Started: Jul 9, 2021 · Completed: Jun 30, 2024
1 condition1 sponsor4 locations
NCT04948203
Assessing the Efficacy of Sirolimus in Patients With COVID-19 Pneumonia for Prevention of Post-COVID Fibrosis
PHASE2/PHASE3Active, not recruiting
60 participants
Started: Jul 9, 2021 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT05997121
Safety and Performance of the Hexanium TLIF System in the Treatment of Degenerative Disc Disease
N/ARecruiting
187 participants
Started: Jul 9, 2021 · Completed: Oct 30, 2027
1 condition2 sponsors6 locations
NCT04807140
Neoadjuvant Toripalimab or Toripalimab in Combination With Carboplatin and Nab-paclitaxel in Untreated HNSCC (HNSCC-002)
PHASE2Recruiting
57 participants
Started: Jul 8, 2021 · Completed: Jan 1, 2027
1 condition1 sponsor1 location
NCT04408495
Intraoperative Mechanical Ventilation and Postoperative Pulmonary Complications After On-pump Cardiac Surgery in High-risk Patients
NAActive, not recruiting
440 participants
Started: Jul 8, 2021 · Completed: Sep 30, 2026
1 condition1 sponsor10 locations
NCT04415424
Efficacy Study of 4CMenB (Bexsero®) to Prevent Gonorrhoea Infection in Gay and Bisexual Men
PHASE3Active, not recruiting
650 participants
Started: Jul 8, 2021 · Completed: Oct 30, 2025
1 condition2 sponsors7 locations
NCT04385082
Cannabis Effects as a Function of Sex
PHASE1Recruiting
160 participants
Started: Jul 8, 2021 · Completed: Jun 30, 2026
2 conditions2 sponsors1 location
NCT06218199
Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts
PHASE4Recruiting
80 participants
Started: Jul 8, 2021 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT04920097
Auricular Point Acupressure to Manage Chemotherapy Induced Neuropathy
NAActive, not recruiting
225 participants
Started: Jul 8, 2021 · Completed: May 30, 2026
1 condition3 sponsors2 locations
NCT05010122
ASTX727, Venetoclax, and Gilteritinib for the Treatment of Newly Diagnosed, Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
PHASE1/PHASE2Recruiting
42 participants
Started: Jul 8, 2021 · Completed: Jan 30, 2026
4 conditions1 sponsor1 location
NCT05793021
FKBP51s: a New Molecular Biomarker for Glioblastoma? Pre- and Post-operative Blood Levels Evaluation of FKBP51s Protein and Correlation With MRI Phenotype
NARecruiting
70 participants
Started: Jul 8, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04613921
Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
N/ARecruiting
3,000 participants
Started: Jul 8, 2021 · Completed: Dec 31, 2026
4 conditions1 sponsor106 locations
NCT04949113
Neoadjuvant Ipilimumab Plus Nivolumab Versus Standard Adjuvant Nivolumab in Macroscopic Stage III Melanoma
PHASE3Active, not recruiting
423 participants
Started: Jul 8, 2021 · Completed: Dec 19, 2028
1 condition2 sponsors24 locations
NCT04707443
Enteral Nutrition in Infants With Ileostomy
N/ARecruiting
110 participants
Started: Jul 8, 2021 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT04829994
Post-Market Clinical Follow-Up onTVT EXACT® Continence System
N/AActive, not recruiting
198 participants
Started: Jul 8, 2021 · Completed: Feb 28, 2036
1 condition1 sponsor8 locations
NCT06298682
Characterization of Exosomes Platelets-released
N/ARecruiting
175 participants
Started: Jul 8, 2021 · Completed: Jul 7, 2027
1 condition2 sponsors1 location
NCT03886181
Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal and Superficial Soft Tissue Neoplasia (DaRT)
NARecruiting
35 participants
Started: Jul 8, 2021 · Completed: Oct 31, 2025
3 conditions1 sponsor1 location
NCT04976959
High Fiber in Parkinson's Disease
PHASE1Active, not recruiting
60 participants
Started: Jul 8, 2021 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT04307303
Electrical Stimulation of Abdominal Muscles for Bowel Management in People With Spinal Cord Injury
NARecruiting
36 participants
Started: Jul 7, 2021 · Completed: May 30, 2024
1 condition2 sponsors1 location
NCT04641286
Clinical Outcome Modelling of Rapid Dynamics in Acute Stroke
N/ARecruiting
8,000 participants
Started: Jul 7, 2021 · Completed: Feb 29, 2028
1 condition3 sponsors1 location
NCT05055635
Pencil Beam Proton Therapy for Recurrences in Anal Cancer Patients Previously Treated With Radiotherapy (DACG 5)
PHASE2Recruiting
55 participants
Started: Jul 7, 2021 · Completed: Jul 6, 2030
2 conditions1 sponsor1 location
NCT04734990
Seclidemstat and Azacitidine for the Treatment of Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
PHASE1/PHASE2Recruiting
44 participants
Started: Jul 7, 2021 · Completed: Sep 11, 2027
6 conditions1 sponsor1 location
NCT04966351
Countermeasures to Circadian Misalignment
NARecruiting
32 participants
Started: Jul 7, 2021 · Completed: Jun 30, 2026
3 conditions4 sponsors1 location
NCT04580810
Black Church Treatment Study
NARecruiting
132 participants
Started: Jul 7, 2021 · Completed: Feb 21, 2026
1 condition2 sponsors3 locations
NCT05105854
Hand Osteoarthritis: Investigating Pain Trajectories and Association With Biomarkers Including Estrogen Cohort
N/AActive, not recruiting
120 participants
Started: Jul 7, 2021 · Completed: Feb 7, 2029
1 condition2 sponsors2 locations